FDA Investigator Remache

Remache has inspections in 1 countries as of 17 Oct 2023. Remache has collaborated with a combinined 2509 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
17 Oct 2023
Investigator Role:
FDA Investigator (Contractor)
Redica ID:
United States of America
Albert M Brindle, Alberto A Viciedo, Amy L Singer, Amy M Cramer, Ana S Cabrera, Anastasia I Offordile, Andrea Ab Bautista, Andrew J Molesky, Annemarie Bodnar, Anthony M Criscuolo, Jr, Antoinette L Ravelli, Barbara J Maulfair, Brandi L Garbutt, Brian R Yaun, Byungja E Marciante, Carol A Perry, Carol A Robles, Cary Greene, Charles I Ann, Charles J Chacko, Charlotte P Chang, Christina N Maurino, Craig W Swanson, David A Schwartz, David H Smith, Dawn L Wydner, Deborah B Goffman, Deborah J Parris, Dessa A Antoine, Devon Jenkins, Dhaval H Patel, Doreen P Gubbay, Dorothy J Denes, Dung N Tran, Edward Oshaughnessy, Emest F Bizjak, Emilio Z Azukwu, Emma A Nesbit, Emmanuel J Ramos, Eric J Cunningham, Eric Rothschild, Frank J Marciniak, Gianine E Delade, Gianine E Tompkins, Gillian B Nardelli, Gobiga Vanniyasingam, Helen B Ricalde, Helen Verdel, Herrmann, Hitesh R Patel, Jason D Tenney, Jason M Sluzynski, Jeff M Uriarte, Jeffrey J Ebersole, Jennifer A Bazergui, Jennifer L Custodio, Jennifer Macmillan, Jessica M Monteiro, Jill M Sooter, Jo Annc Declement, Jose M Cayuela, Joseph Duca, Joy F Canlas, Judith A Jones, Judith A Paterson, Karen E D'orazio, Karen F Tomaziefski, Keith A Schwartz, Keith M Reilly, Kelli F Dobilas, Kelly Doremus, Kelly I Anderson, Kerry A Kurdilla, King, Kinh Q Mac, Kris K Moore, Kristen E Rescigno, Krystal O Ogunremi, Kwong P Lee, Kyle D Covill, Laishan L Lam, Lata C Mathew, PhD, Lauren L Vajo, Lawrence R Johnson, LCDR Audra J Lenhart, Li Li, Liatte Kreuger, PharmD, Lisa B Hall, Lisa Harlan, Lisa Mathew, Loretta Nemchik, Marcelo O Mangalindan, Jr, Maria Estrella, Marjorie D Schultz, Melba Trivera Clavell, Melissa A Freeman, Melissa B Libby, Meredith L Sheridan, Michael L Casner, Michael R Klapal, Michael Rosner, Michael Serrano, Mielziner, Miguel G Manzano, Niketa Patel, Nina Yang, Noreen Kurzam, Patricia Niebanck, Paul L Bellamy, Peter R Lenahan, Ramanda C Gregory, Raymond L Cheung, Richard D Manney, Robert W Calais, Rodrigo Vilchez, Russell J Glapion, Sandra Kershaw, Sands, Sarah Forney, Schultz, Sean G Casey, Seng Ching Hwang, Sharon Ferraro, Sheri L Stephenson, Sherri J Liu, Shirley S Wen, Sinai Davis, State Agency, Stephanie T Durso, Stephen J Mottola, Susan M Halsted, Tamil Arasu, PhD, Tammy M Phillips, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Teigan M Mule, Tonia F Bernard, Tracey L Harris, Tressa T Lewis, Unnee Ranjan, Valerie C Reed, Wayne J Meyer, Whitney S Reynolds, William J Muszynski, William W Dotts, Yessika Mashinski, Zakaria I Ganiyu

Remache's Documents

Publish Date Document Type Title
November, 2003 EIR Square Enterprises Corporation - EIR, 2003-11-24
November, 2003 FDA 483 Square Enterprises Corporation - Form 483, 2003-11-24

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more